Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor

This publication has 24 references indexed in Scilit:

• Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary Intervention
  Circulation, 1995
• Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain.
  Circulation, 1994
• Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
  Stroke, 1994
• Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs.
  Circulation, 1994
• Inhibition of platelet retention on artificial microvascular grafts with monoclonal antibodies and a high-affinity peptide directed against platelet membrane glycoproteins.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.
  Circulation, 1990
• Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
  Circulation, 1990
• Effects of an antiplatelet glycoprotein Ib antibody on hemostatic function in the guinea pig
  Blood, 1989
• Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
  Circulation, 1988
• Shear Rate Dependent Inhibition of Platelet Adhesion and Aggregation on Collagenous Surfaces by Antibodies to Human Factor VIII/von Willebrand Factor
  British Journal of Haematology, 1980